Connect with us

Health

Blood test flags digestive disease risk years before symptoms appear

Published

on

Blood test flags digestive disease risk years before symptoms appear

NEWYou can now listen to Fox News articles!

A simple blood test may detect Crohn’s disease years before symptoms appear, according to a new study reported by SWNS.

Canadian researchers say the discovery could enable earlier diagnosis and potential prevention of the chronic inflammatory bowel disease (IBD).

The test measures the immune system’s response to flagellin, a protein found in gut bacteria. Researchers found that this response is elevated in some people years before Crohn’s develops.

DOCTOR WARNS OF 2 SIMPLE FOOD MISTAKES THAT INCREASE CHRONIC DISEASE RISK

Advertisement

The findings, published in Clinical Gastroenterology and Hepatology, highlight the “interplay” between gut bacteria and immune system responses as a key step in the disease’s development, per the SWNS report.

Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that causes persistent digestive symptoms, pain and fatigue, significantly affecting quality of life. Its incidence among children has doubled since 1995, according to official figures.

Crohn’s disease is a type of inflammatory bowel disease (IBD) that causes swelling and irritation of the tissues, called inflammation, in the digestive tract.  (iStock)

The presence of flagellin antibodies long before symptoms appear suggests that the immune reaction may help trigger the disease, according to research leader Dr. Ken Croitoru, clinician-scientist and professor of medicine and immunology at the University of Toronto. 

A better understanding of this early process could lead to improved prediction, prevention and treatment, the expert said.

Advertisement

“We haven’t cured anybody yet, and we need to do better.”

“With all the advanced biologic therapy we have today, patients’ responses are partial at best,” Croitoru told SWNS. “We haven’t cured anybody yet, and we need to do better.”

MISUNDERSTOOD ILLNESS LEAVES MILLIONS EXHAUSTED, WITH MOST CASES UNDIAGNOSED

“We wanted to know: Do people who are at risk, who are healthy now, have these antibodies against flagellin?” he said. “We looked, we measured, and yes indeed, at least some of them did.”

This new research is part of the Genetic, Environmental and Microbial (GEM) Project, which has followed more than 5,000 healthy first-degree relatives of people with Crohn’s disease worldwide since 2008. The project collects genetic, biological and environmental data to better understand how the disease develops.

Advertisement

The presence of flagellin antibodies long before symptoms appear suggests that the immune reaction may help trigger the disease, according to the lead researcher. (iStock)

The study followed 381 first-degree relatives of Crohn’s patients, 77 of whom later developed the disease. Of those, more than 30% had elevated antibody responses.

The responses were strongest in siblings, underscoring the role of shared environmental exposure, researchers said.

CLICK HERE FOR MORE HEALTH STORIES

So far, 130 of the study participants have developed Crohn’s, giving researchers a rare opportunity to study its earliest stages. The average time from blood sample collection to diagnosis was nearly 2-½ years.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Previous GEM research showed that an inflammatory immune response targeting gut bacteria can appear long before the disease develops. 

The study followed 381 first-degree relatives of Crohn’s patients, 77 of whom later developed the disease. (iStock)

In healthy people, gut bacteria coexist peacefully and play an essential role in digestive health — but in Crohn’s patients, the immune system appears to mount an abnormal response against the microbes, experts say.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

The Canadian team also confirmed that this pre-disease immune response was associated with intestinal inflammation and gut barrier dysfunction, both hallmarks of Crohn’s disease. 

The study did have some limitations, including that it did not include experiments to show exactly how the immune response might lead to Crohn’s disease.  (iStock)

Research team member Dr. Sun-Ho Lee, a gastroenterologist, commented that this new study supports the idea of designing a flagellin-directed vaccine for certain high-risk individuals to prevent the disease, according to SWNS.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study did have some limitations, including that it did not include experiments to show exactly how the immune response might lead to Crohn’s disease. 

Advertisement

As a result, the researchers could not determine the biological steps linking the immune reaction to the onset of the illness. “Further validation and mechanistic studies are underway,” they noted.

Health

Video: Wii Bowling Takes Over Tulsa Retirement Homes

Published

on

Video: Wii Bowling Takes Over Tulsa Retirement Homes

new video loaded: Wii Bowling Takes Over Tulsa Retirement Homes

transcript

transcript

Wii Bowling Takes Over Tulsa Retirement Homes

Retirement communities in Tulsa, Okla., compete against one another in a Nintendo Wii Sports bowling league.

“That’s how you win.” “There you go, Ron.” “Way to go.”

Advertisement
Retirement communities in Tulsa, Okla., compete against one another in a Nintendo Wii Sports bowling league.

By Nick Oxford, Alisa Shodiyev Kaff and Alexandra E. Petri

June 19, 2026

Continue Reading

Health

Weight-loss drugs linked to ‘Ozempic ears’ and other cosmetic complaints, surgeons say

Published

on

Weight-loss drugs linked to ‘Ozempic ears’ and other cosmetic complaints, surgeons say

NEWYou can now listen to Fox News articles!

As the popularity of GLP-1 drugs continues to climb, significant weight loss associated with the medications has been linked to a growing list of cosmetic concerns.

Some surgeons report that more patients are seeking treatments for so-called “Ozempic earlobes,” which reportedly appear thinner, longer or more sagging after the loss of facial fat.

“The use of semaglutides causes you to lose fat across your body, including the small, fat pads of the earlobes,” facial plastic surgeon Sachin S. Parikh, MD, told NewBeauty.

OZEMPIC, OTHER SEMAGLUTIDES LINKED TO HAIR LOSS: HERE’S WHAT TO KNOW

Advertisement

“It’s important to note that semaglutides do not damage ear tissue or affect hearing in any way, so any intervention would be purely cosmetic,” added the California-based doctor.

Some of the potential treatments for “Ozempic earlobes” may include dermal filler, fat transfer, laser treatments or surgical earlobe reduction, according to the report.

As the popularity of GLP-1 drugs continues to climb, significant weight loss associated with the medications has been linked to a growing list of cosmetic concerns. (iStock)

Dr. Mohammed Asif from Duly Health and Care in Naperville, Illinois, said that while he hasn’t personally noticed an uptick in ear surgeries, he has seen a rise in other procedures due to GLP-1-triggered weight loss.

Some of those include panniculectomies (Ozempic skin removal surgery) and abdominoplasties (tummy tucks).

Advertisement

PLASTIC SURGERY TRENDS TAKE A SURPRISING TURN, AS DOCTORS SEE MORE PATIENTS ‘SIZING DOWN’

“There has been a significant increase in body contouring procedures among patients with GLP-1 weight loss,” Asif told Fox News Digital. 

“In my practice, I’ve seen a significant surge in breast lifts, panniculectomies (skin removal surgery), abdominoplasties (tummy tucks), brachioplasties (arm lifts) and thighplasties due to weight loss.”

TOP COSMETIC PROCEDURES REVEALED IN NEW REPORT: WHAT’S TRENDING AND WHY

Healing and recovery are “far greater and less complicated” than with bariatric surgery weight loss, Asif noted.

Advertisement

“This is due to the gradual weight loss achieved over time with GLP-1s.”

“Ozempic breast” is another common complaint, according to Dr. Michael Omidi, a double board-certified plastic surgeon practicing in Beverly Hills.

“There has been a significant increase in body contouring procedures among patients with GLP-1 weight loss,” a doctor told Fox News Digital. (iStock)

“Women in their 30s and 40s would not typically need a breast lift, but when you’re taking drugs like Ozempic or Wegovy that cause rapid weight loss, women can see gravity take its toll on their breasts,” he told Fox News Digital. 

“When women, especially younger ones, lose fat too fast, it causes the breasts, which are comprised of fat, glandular tissue and skin, to lose volume,” he went on. “The skin and supporting ligaments don’t always bouce back at the same rate as the weight loss, resulting in breasts that can appear saggy and deflated.”

Advertisement

NEW OBESITY TREATMENT MAY HELP PRESERVE MUSCLE DURING WEIGHT LOSS

Dr. Samuel Golpanian, a double board-certified plastic surgeon in Beverly Hills, said he has seen “dozens” of patients – men and women alike – seeking treatments for so-called “Ozempic butt” after significant weight loss.

“This is an unintended consequence of taking GLP-1s,” he told Fox News Digital.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Such dramatic weight loss in a short period of time causes the skin not to tighten quickly enough to keep up with the body’s changes. Our buttocks have a large amount of fat, so when that volume disappears quickly, you’ll develop a flatter, saggier behind.”

Advertisement

“Such dramatic weight loss in a short period of time causes the skin not to tighten quickly enough to keep up with the body’s changes,” a surgeon said. (iStock)

Kristy Hamilton, MD, a Houston-based surgeon who is a member of the American Society of Plastic Surgeons (ASPS), agreed that a growing number of patients are seeking skin-tightening procedures after losing large amounts of weight with GLP-1s.

“We’re absolutely seeing more of those patients, and I expect that trend to continue,” said Hamilton in an ASPS report.

CLICK HERE FOR MORE HEALTH STORIES

“People are losing as much as 100 pounds on this medication – and when you’re losing that amount, that’s significant. You’re certainly going to have excess skin afterward.”

Advertisement

The ASPS lists the following body-contouring procedures as the ones most frequently performed after substantial weight loss.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

  • Tummy tuck (abdominoplasty): Removes excess abdominal skin and fat
  • Lower body lift (belt lipectomy): Addresses the abdomen, buttocks, hips and thighs
  • Arm lift (brachioplasty): Removes hanging upper-arm skin
  • Thigh lift: Tightens excess skin of the inner thighs
  • Breast lift (mastopexy): Addresses sagging, deflated breasts after weight loss
  • Facelift/neck lift: Addresses facial volume loss and skin laxity after major weight loss

“People are losing as much as 100 pounds on this medication – and when you’re losing that amount, that’s significant. You’re certainly going to have excess skin afterward.” (iStock)

Experts say adequate protein intake and resistance training can help minimize the loss of lean muscle mass that often accompanies rapid weight loss, which could reduce some of the cosmetic concerns.

Golpanian also emphasized the importance of eating enough protein.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“It can be harder since your appetite is suppressed, but it’s so important to consume at least 110 grams of protein a day while taking a GLP-1 drug,” he advised. 

“Also, I say this to my patients all the time: You have to lift weights to keep your muscles from atrophying. Strength training can help build muscles and preserve your glutes.”

Advertisement
Continue Reading

Health

New At-Home DNA Test Reveals if GLP-1 Weight-Loss Drugs Will Work for You

Published

on

New At-Home DNA Test Reveals if GLP-1 Weight-Loss Drugs Will Work for You


Advertisement





GLP-1 Test Predicts If Weight Loss Drugs Will Work for You




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading
Advertisement

Trending